rediff.com
e.g. Tata motors, Reliance MF, 500570
Par Drugs & Chemicals Ltd. - Research Center
Group () BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Balance sheet
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Sources of funds
Owner's fund
Equity share capital 12.30 12.30 12.30 6.15 6.15
Share application money - - - - -
Preference share capital - - - - -
Reserves & surplus 73.33 58.93 47.57 46.06 34.46
Loan funds
Secured loans - - - 7.64 4.62
Unsecured loans - - - - -
Total 85.63 71.24 59.88 59.85 45.23
Uses of funds
Fixed assets
Gross block 73.84 67.57 60.02 52.54 34.40
Less : revaluation reserve - - - - -
Less : accumulated depreciation 32.53 29.12 25.91 22.63 -
Net block 41.31 38.45 34.10 29.91 34.40
Capital work-in-progress 0.03 0.25 0.25 4.52 0.74
Investments 0.01 0.01 0.01 0.01 0.06
Net current assets
Current assets, loans & advances 60.26 50.16 44.33 41.94 24.92
Less : current liabilities & provisions 15.98 17.63 18.81 16.53 14.88
Total net current assets 44.29 32.53 25.52 25.41 10.04
Miscellaneous expenses not written - - - - -
Total 85.63 71.24 59.88 59.85 45.23
Notes:
Book value of unquoted investments - - - - 0.06
Market value of quoted investments - - - - -
Contingent liabilities 0.10 - - 0.24 0.24
Number of equity sharesoutstanding (Lacs) 123.05 123.05 123.05 61.52 61.52
Close
Add Par Drugs & Chemicals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Par Drugs & Chemicals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close